Abstract

Problem statement: Recent technological and scientific advances propelled the field of Genome-Wide Association Study (GWAS), which promises to be instrumental in linking many common complex diseases to their genetic origin. While so far such large-scale surveys have been moderately successful in identifying disease related genetic variants, much of disease heritability is still not accounted for by the discovered loci. There is an urgent need for advanced statistical methods for efficient automatic detection of complicated multilocus interactions on significant scales. Approach: Novel statistical methods based on Bayesian data analysis ideas, specifically Bayesian modeling, Bayesian variable partitioning, graphical and network models are promising to aid in search for missing disease heritability and shed light on complex biological processes involved in disease development. First crucial difference setting these methods apart from all the mainstream previous approaches (hypothesis testing methods) is their joint disease mapping capability via the simultaneous fitting of a statistical model for the whole case-control data set. Additionally, such Bayesian methods allow for the construction of complicated data models and quantitative incorporation of diverse prior information into the final statistical model. Results: The use of Bayesian techniques has already yielded new insights into the details of epistatic interactions across the genome associated with various important diseases. Conclusion/Recommendations: Bayesian approaches provide a way to detect and understand complicated multilocus interactions that already started to elucidate important disease pathways. As the field of GWAS matures, Bayesian strategies can surely aid in converting such multiple surveys into useful biomedical information.

Highlights

  • The promise of personalized medicine and genomics: Improved disease prevention and diagnosis as well as novel routes to therapies are the main motivations for extensive studies aimed at finding disease related genes and variants

  • Later on we address in detail how Bayesian strategies can address the burning problems in genetics while dealing with epistasis and linkage disequilibrium. (WTCCC, 2007; Johnson and O’Donnell, 2009), discovered variants explain only a small proportion of the observed familial aggregation (McCarthy et al, 2008; Altshuler and Daly, 2007)

  • The major problem with Genome-Wide Association Study (GWAS) approaches is that the determined disease associated genetic regions explain only a small part of the disease heritability (Donnelly, 2008; WTCCC, 2007)

Read more

Summary

INTRODUCTION

The promise of personalized medicine and genomics: Improved disease prevention and diagnosis as well as novel routes to therapies are the main motivations for extensive studies aimed at finding disease related genes and variants. Statistical approaches for GWAS: Currently, most of the approaches to disease association mapping employ the standard ‘frequentist’ attitude to the evaluation of significance (McCarthy et al, 2008) Such algorithms use hypothesis testing procedures to deal with one variant at a time (Zhang, 2012). The accepted threshold for the p-value is ~ 5×10−8 (Risch and Merikangas, 1996; Hoggart et al, 2008; McCarthy et al, 2008) Failures of such ‘frequentist’ methods to account for the power of a study and the number of likely true positives (McCarthy et al, 2008) combined with the increased likelihood to report a multitude of redundant associations (Zhang, 2012) sparked a wide interest in the Bayesian procedures. Biological processes like metabolism, signal transduction and gene regulations and, genetic

MATERIALS AND METHODS
DISCUSSION
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.